İbrahim Karadağ

6PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Medical biochemistry - lipids
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 14, 2026
Baseline vitamin D status and clinical outcomes in advanced non-small cell lung cancer patients treated with nivolumab.

Gözde Ağdaş, Duygu Bayir, Elif Şahin

|Jan 28, 2026
Dynamic Immune-Nutritional Indices as Powerful Predictors of Pathological Complete Response in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Emel Mutlu Ozkan, Ibrahim Karadag, Mevlude Inanc

|Mar 30, 2023
The Potential Prognostic Marker TyG Index Predicts Time to Brain Metastasis at HER2 Positive Breast Cancer.

Ibrahim Karadag, Serdar Karakaya, Tolga Akkan

|Mar 02, 2023
Clinicopathological features of non-carcinoid malignant epithelial appendix tumors and risk factors for recurrence, single-center experience.

Ozturk Ates, Bulent Aksel, Ibrahim Karadag

|Aug 03, 2021
Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy.

Cengiz Karacin, Tulay Eren, Esra Zeynelgil

|Feb 15, 2019
The neutrophil-lymphocyte ratio and its relationship with insulin resistance in obesity

Serdar Karakaya, Mustafa Altay, Fatma Kaplan Efe

Pageof 1

Frequent Collaborators

2 joint publications

Serdar Karakaya

2 joint publications

Metin Ozkan

2 joint publications

Mevlude Inanc

2 joint publications

Emel Mutlu Ozkan